In summary, our work systematically investigated the expression of PKM2 in LUAD, and identified that over-expressed PKM2 was significantly associated with increasing tumor stage, lymph node metastasis, and worse survival time (OS, PPS, FP and RFS). The gene discussed is PKM; the disease is neoplasm.